EssilorLuxottica's recommendation has been downgraded by UBS from 'buy' to 'neutral', with the price target being raised from 232 to 248 euros. This suggests a potential upside of 7% for the company's shares.
UBS acknowledges the positive prospects for sales acceleration but expresses concerns about the high valuation and risks associated with customs tariffs. UBS advises investors to approach with caution and suggests taking a pause to reassess the situation regarding the Franco-Italian optical giant. The firm emphasizes the importance of being aware of potential market challenges while recognizing the company's growth potential.